Pericarditis: Difference between revisions
Elcatracho (talk | contribs) |
|||
| (10 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
[[File:Pericarditis.jpg|thumbnail|Pericarditis compared with normal pericardium]] | [[File:Pericarditis.jpg|thumbnail|Pericarditis compared with normal pericardium]] | ||
[[File:2004 Heart Wall.jpg|thumb|Anatomy of the pericardium.]] | |||
*Inflammation of the pericardium | *Inflammation of the pericardium | ||
===Etiology=== | ===Etiology=== | ||
*Idiopathic (25-85%) | *Idiopathic (25-85%) | ||
| Line 47: | Line 49: | ||
==Evaluation== | ==Evaluation== | ||
===Diagnostic Criteria for Acute Pericarditis<ref>Imazio M, Gaita F, LeWinter M. Evaluation and Treatment of Pericarditis: A Systematic Review. JAMA 2015;314(14):1498–506.</ref>=== | ===Diagnostic Criteria for Acute Pericarditis<ref>Imazio M, Gaita F, LeWinter M. Evaluation and Treatment of Pericarditis: A Systematic Review. JAMA 2015;314(14):1498–506.</ref>=== | ||
*Need 2 of the following | *Need 2 of the following: | ||
**Chest pain (typically sharp and pleuritic, improved by sitting up and leaning forward) | **Chest pain (typically sharp and pleuritic, improved by sitting up and leaning forward) | ||
**Pericardial friction rub (best heard at the LSB, with pt leaning forward at end-expiration) | **Pericardial friction rub (best heard at the LSB, with pt leaning forward at end-expiration) | ||
| Line 60: | Line 62: | ||
**[[Troponin]] elevation may indicate a concurrent [[myocarditis]] which predispose to risk of [[CHF]] or [[arrhythmias|arrhythmia]]. <ref>LeWinter MM, et al. Clinical practice. Acute pericarditis. N Engl J Med. 2014 Dec 18;371(25):2410-6. PMID: 25517707.</ref> | **[[Troponin]] elevation may indicate a concurrent [[myocarditis]] which predispose to risk of [[CHF]] or [[arrhythmias|arrhythmia]]. <ref>LeWinter MM, et al. Clinical practice. Acute pericarditis. N Engl J Med. 2014 Dec 18;371(25):2410-6. PMID: 25517707.</ref> | ||
*[[CXR]] | *[[CXR]] | ||
**Typically normal if no pericardial effusion. | |||
**Will not see increase in cardiac silhouette size until > 300mL of pericardial fluid has accumulated | |||
*Bedside Ultrasound to rule out effusion | *Bedside Ultrasound to rule out effusion | ||
**~2/3 of cases will have pericardial effusion<ref>LeWinter MM. Clinical practice. Acute pericarditis. N Engl J Med. 2014 Dec 18;371(25):2410-6. doi: 10.1056/NEJMcp1404070. Review. </ref> | **~2/3 of cases will have pericardial effusion<ref>LeWinter MM. Clinical practice. Acute pericarditis. N Engl J Med. 2014 Dec 18;371(25):2410-6. doi: 10.1056/NEJMcp1404070. Review. </ref> | ||
| Line 65: | Line 69: | ||
===ECG=== | ===ECG=== | ||
[[File:ECG000026-2. | [[File:ECG000026-2.png|thumb|Acute pericarditis with clear diffuse ST elevation and some PTa depression]] | ||
====Classical Teachings with Caveats Below==== | ====Classical Teachings with Caveats Below==== | ||
*Must differentiate from [[STEMI]] (classical teachings are not specific enough to do that) | *Must differentiate from [[STEMI]] (classical teachings are not specific enough to do that) | ||
| Line 78: | Line 82: | ||
**PR-depression is often early and transient in pericarditis | **PR-depression is often early and transient in pericarditis | ||
**In [[STEMI]], PR-depression is associated with atrial injury, though usually not as marked as in viral pericarditis<ref>Wang K, Asinger RW, and Marriott HJL. ST-segment Elevation in Conditions Other than Acute Myocardial Infarction. N Engl J Med 2003;349:2128-35.</ref> | **In [[STEMI]], PR-depression is associated with atrial injury, though usually not as marked as in viral pericarditis<ref>Wang K, Asinger RW, and Marriott HJL. ST-segment Elevation in Conditions Other than Acute Myocardial Infarction. N Engl J Med 2003;349:2128-35.</ref> | ||
**PR-elevation in aVR may also be present in [[STEMI]] and is infrequently seen in constrictive pericarditis | **PR-elevation in aVR may also be present in [[STEMI]] and is infrequently seen in [[constrictive pericarditis]] | ||
====Other Findings==== | ====Other Findings==== | ||
| Line 89: | Line 93: | ||
**If (STE)/(T height) in V6 or I > 0.25, then it is likely pericarditis | **If (STE)/(T height) in V6 or I > 0.25, then it is likely pericarditis | ||
*If predominantly inferior STE, ST-depression in aVL is sensitive for STEMI<ref>Bischof JE, Worrall C, Thompson P, et al. ST depression in lead aVL differentiates inferior ST-elevation myocardial infarction from pericarditis. Am J Emerg Med. 2016; 34(2):149-154.</ref> | *If predominantly inferior STE, ST-depression in aVL is sensitive for STEMI<ref>Bischof JE, Worrall C, Thompson P, et al. ST depression in lead aVL differentiates inferior ST-elevation myocardial infarction from pericarditis. Am J Emerg Med. 2016; 34(2):149-154.</ref> | ||
*Spodick's sign | *Spodick's sign- Downsloping of the TP segment; often best seen in lead II and lateral precordial leads<ref>Chaubey VK and Chhabra L. Spodick’s Sign: A Helpful Electrocardiographic Clue to the Diagnosis of Acute Pericarditis. Perm J. 2014 Winter; 18(1): e122.</ref> | ||
**Suggestive but not diagnostic for acute pericarditis | |||
[[File:ST-T ratio.jpg|thumbnail]] | [[File:ST-T ratio.jpg|thumbnail]] | ||
[[File:Spodick's_sign.JPG|thumbnail|Spodick's sign]] | [[File:Spodick's_sign.JPG|thumbnail|Spodick's sign]] | ||
| Line 115: | Line 120: | ||
===Initial Treatment=== | ===Initial Treatment=== | ||
*'''[[NSAIDS]] or [[Aspirin]]: '''first line treatment (in absence of contraindications) for viral or idiopathic pericarditis.<ref>Imazio M. A randomized trial of colchicine for acute pericarditis.N Engl J Med. 2013 Oct 17;369(16):1522-8 [http://www.nejm.org/doi/pdf/10.1056/NEJMoa1208536 PDF]</ref> | *'''[[NSAIDS]] or [[Aspirin]]: '''first line treatment (in absence of contraindications) for viral or idiopathic pericarditis.<ref>Imazio M. A randomized trial of colchicine for acute pericarditis.N Engl J Med. 2013 Oct 17;369(16):1522-8 [http://www.nejm.org/doi/pdf/10.1056/NEJMoa1208536 PDF]</ref> | ||
**[[Aspirin]] | **[[Aspirin]] 650mg every 6 hours for 7 to 10 days, followed by tapering during a period of 3 to 4 weeks '''OR''' | ||
**[[Ibuprofen]] 600mg every 8 hours for 7 to 10 days, followed by tapering during a period of 3 to 4 weeks | **[[Ibuprofen]] 600mg every 8 hours for 7 to 10 days, followed by tapering during a period of 3 to 4 weeks | ||
*'''[[Colchicine]]''' add to [[NSAIDs]] as first line treatment for viral/idiopathic acute and recurrent pericarditis to improve remission rates and prevent recurrence.<ref>ImazioM, BobbioM, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis. Circulation. 2005;112(13):2012-2016.</ref> | *'''[[Colchicine]]''' add to [[NSAIDs]] as first line treatment for viral/idiopathic acute and recurrent pericarditis to improve remission rates and prevent recurrence.<ref>ImazioM, BobbioM, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis. Circulation. 2005;112(13):2012-2016.</ref> | ||
| Line 166: | Line 171: | ||
**Usually weeks to months after initial episode | **Usually weeks to months after initial episode | ||
**Management is same | **Management is same | ||
*Constrictive Pericarditis | *[[Constrictive Pericarditis]] | ||
**Related to etiology; increased risk with bacterial pericarditis, rare with viral/idiopathic etiology | **Related to etiology; increased risk with bacterial pericarditis, rare with viral/idiopathic etiology | ||
**Also can be caused by radiation exposure | |||
**Restrictive picture with pericardial calcifications on CXR, thickened on TTE | **Restrictive picture with pericardial calcifications on CXR, thickened on TTE | ||
**Treat with pericardial window | **Treat with pericardial window | ||
| Line 174: | Line 180: | ||
*[https://www.youtube.com/watch?v=XVCEPy5KH_w Mattu ECG Case: Sept 3, 2012 - Pericarditis vs. STEMI] | *[https://www.youtube.com/watch?v=XVCEPy5KH_w Mattu ECG Case: Sept 3, 2012 - Pericarditis vs. STEMI] | ||
*[https://journalfeed.org/article-a-day/2020/differentiating-stemi-from-pericarditis Differentiating STEMI from Pericarditis.] | *[https://journalfeed.org/article-a-day/2020/differentiating-stemi-from-pericarditis Differentiating STEMI from Pericarditis.] | ||
*[http://www.emdocs.net/em3am-pericarditis/ emDocs - Pericarditis] | |||
==See Also== | ==See Also== | ||
| Line 179: | Line 186: | ||
*[[STEMI]] | *[[STEMI]] | ||
*[[Myocardial infarction complications]] | *[[Myocardial infarction complications]] | ||
*[[Constrictive pericarditis]] | |||
==References== | ==References== | ||
Latest revision as of 18:19, 26 June 2023
Background
- Inflammation of the pericardium
Etiology
- Idiopathic (25-85%)
- Infection (up to 20%)
- Malignancy
- Hematologic
- Lung
- Breast
- Primary cancers of the pericardium are rare but potential causes
- Uremia
- Chronic kidney failure
- Post radiation
- Connective tissue disease or other autoimmune conditions
- Drugs:
- Procainamide
- Hydralazine
- Methyldopa
- Phenytoin
- Anticoagulants (especially warfarin and heparin)
- Cardiac injury (can see up to weeks later)
- Post MI (Dressler's syndrome)
- Thoracic trauma
- Aortic dissection
- Cardiac surgery
Clinical Features
- Pleuritic chest pain
- Radiates to chest, back, trapezius ridge (inferior portion of the scapula)
- trapezius ridge muscles innervated by phrenic n. which also traverses pericardium.
- Diminishes with sitting up/leaning forward
- Radiates to chest, back, trapezius ridge (inferior portion of the scapula)
- Shortness of breath
- Especially if concommitant pleural effusion
- Hypotension/extremis if cardiac tamponade
- Fever, chills, myalgias (systemic signs with viral infection)
- Friction rub
Differential Diagnosis
ST Elevation
- Cardiac
- ST-segment elevation myocardial infarction (STEMI)
- Post-MI (ventricular aneurysm pattern)
- Previous MI with recurrent ischemia in same area
- Wellens' syndrome
- Coronary artery vasospasm (eg, Prinzmetal's angina)
- Coronary artery dissection
- Pericarditis
- Myocarditis
- Aortic dissection in to coronary
- Left ventricular aneurysm
- Left ventricular pseudoaneurysm
- Early repolarization
- Left bundle branch block
- Left ventricular hypertrophy (LVH)
- Myocardial tumor
- Myocardial trauma
- RV pacing (appears as Left bundle branch block)
- Brugada syndrome
- Takotsubo cardiomyopathy
- AVR ST elevation
- Other thoracic
- Metabolic
- Drugs of abuse (eg, cocaine, crack, meth)
- Hyperkalemia (only leads V1 and V2)
- Hypothermia ("Osborn J waves")
- Medications
Chest pain
Critical
- Acute coronary syndromes (ACS)
- Aortic dissection
- Cardiac tamponade
- Coronary artery dissection
- Esophageal perforation (Boerhhaave's syndrome)
- Pulmonary embolism
- Tension pneumothorax
Emergent
- Cholecystitis
- Cocaine-associated chest pain
- Mediastinitis
- Myocardial rupture
- Myocarditis
- Pancreatitis
- Pericarditis
- Pneumothorax
Nonemergent
- Aortic stenosis
- Arthritis
- Asthma exacerbation
- Biliary colic
- Costochondritis
- Esophageal spasm
- Gastroesophageal reflux disease
- Herpes zoster / Postherpetic Neuralgia
- Hypertrophic cardiomyopathy
- Hyperventilation
- Mitral valve prolapse
- Panic attack
- Peptic ulcer disease
- Pleuritis
- Pneumomediastinum
- Pneumonia
- Rib fracture
- Stable angina
- Thoracic outlet syndrome
- Valvular heart disease
- Muscle sprain
- Psychologic / Somatic Chest Pain
- Spinal Root Compression
- Tumor
Evaluation
Diagnostic Criteria for Acute Pericarditis[1]
- Need 2 of the following:
- Chest pain (typically sharp and pleuritic, improved by sitting up and leaning forward)
- Pericardial friction rub (best heard at the LSB, with pt leaning forward at end-expiration)
- New or worsening pericardial effusion
- Suggestive ECG changes
Work-Up
- ECG
- Labs
- WBC, CMP, ESR, CRP
- Consider TSH, ANA based on clinical suspicion
- Troponin elevation may indicate a concurrent myocarditis which predispose to risk of CHF or arrhythmia. [2]
- CXR
- Typically normal if no pericardial effusion.
- Will not see increase in cardiac silhouette size until > 300mL of pericardial fluid has accumulated
- Bedside Ultrasound to rule out effusion
- ~2/3 of cases will have pericardial effusion[3]
- Can consider CT or cardiac MRI if workup non-diagnostic and clinical suspicion persists
ECG
Classical Teachings with Caveats Below
- Must differentiate from STEMI (classical teachings are not specific enough to do that)
- Classically pericarditis has diffuse ST-elevations
- However, pericarditis may generate localized ST-elevations
- Pericarditis should never produce ST-depressions (suggestive of reciprocal changes), except in V1 and aVR
- Classically pericardidits has concave upwards STE
- Classically pericardititis has PR-depression in viral pericarditis (or PR-elevation in AVR)
- Less reliable in post-MI patients and those with baseline ECG abnormalities
- PR-depression is often early and transient in pericarditis
- In STEMI, PR-depression is associated with atrial injury, though usually not as marked as in viral pericarditis[4]
- PR-elevation in aVR may also be present in STEMI and is infrequently seen in constrictive pericarditis
Other Findings
- Leads II and III
- STE II > STE III favors pericarditis
- STE III > STE II very strongly favors STEMI
- STD not in aVR or V1 (reciprocol changes) suggestive of STEMI
- May see low voltage/alternans if effusion present
- If early repolarization confounding interpretation check ST:T ratio
- If (STE)/(T height) in V6 or I > 0.25, then it is likely pericarditis
- If predominantly inferior STE, ST-depression in aVL is sensitive for STEMI[5]
- Spodick's sign- Downsloping of the TP segment; often best seen in lead II and lateral precordial leads[6]
- Suggestive but not diagnostic for acute pericarditis
- TWI don't invert in pericarditis until STE resolved; if TWI and STE simultaneously present, more likely ACS/MI
Stages of Progression
- Stage I:
- Global concave up ST elevation in all leads (especially V4-6, I, II) except aVR, V1 and III
- PTa depression (depression between the end of the P-wave and the beginning of the QRS- complex)
- Stage II:
- "Pseudonormalisation"
- ST segments return to baseline
- Large T waves
- PR depression
- Stage III:
- T wave flattening progressing to inversion
- Stage IV:
- Return to baseline
STEMI vs Pericarditis
| Disease | STEMI | Pericarditis |
| Pain | Constant | Varies with motion |
| Fever | No | Yes |
| ST changes | focal | Diffuse elevation |
| Reciprocal changes | Yes | No |
| Q waves | Yes | No |
| Pulmonary edema | Sometimes | No |
| Wall motion | Abnormal | Normal |
Management
Initial Treatment
- NSAIDS or Aspirin: first line treatment (in absence of contraindications) for viral or idiopathic pericarditis.[7]
- Colchicine add to NSAIDs as first line treatment for viral/idiopathic acute and recurrent pericarditis to improve remission rates and prevent recurrence.[8]
- Patients >70kg - 0.6mg PO BID x 3 months
- Patients<70kg - 0.6mg PO Daily x 3 months
- Glucocorticoid therapy second line agent for viral/idiopathic pericarditis, can consider low-moderate doses for patients with contraindications to NSAIDs or persistent symptoms despite appropriate therapy with NSAIDs + colchicine for at least 1 week. Also used for etiologies that are steroid responsive diseases.
- Prednisone 0.2 to 0.5mg/kg of body weight per day for 2 weeks with gradual tapering[9]
Recurrent or Refractory
For recurrent or refractory cases consider colchicine and or steroids although literature suggests it can be used as first line[10]
- Colchicine
- Patients >70kg - 0.6mg PO BID x 6 months
- Patients<70kg - 0.6mg PO Daily x 6 months
- If patients develop serious diarrhea decrease their dosing to the next weight class or stop treatment.
Contraindications to Colchicine[11]
- Tuberculous
- Neoplastic pericarditis
- Liver disease or aminotransferase levels ≥1.5x upper limits of normal
- Creatinine >2.5mg/dL (>221 umol/L)
- Myopathy or CK > upper limits of normal
- Inflammatory bowel disease
- Life expectancy ≤18 months
- Pregnancy or lactation
Uremic Pericarditis
- The definitive treatment is dialysis
Tamponade
- Tamponade requires pericardiocentesis
Disposition
- Hospitalization is not necessary in most cases
- Consider admission for:
Complications
- Pericardial Effusion and Tamponade
- Recurrence
- Usually weeks to months after initial episode
- Management is same
- Constrictive Pericarditis
- Related to etiology; increased risk with bacterial pericarditis, rare with viral/idiopathic etiology
- Also can be caused by radiation exposure
- Restrictive picture with pericardial calcifications on CXR, thickened on TTE
- Treat with pericardial window
External Links
- Mattu ECG Case: Sept 3, 2012 - Pericarditis vs. STEMI
- Differentiating STEMI from Pericarditis.
- emDocs - Pericarditis
See Also
References
- ↑ Imazio M, Gaita F, LeWinter M. Evaluation and Treatment of Pericarditis: A Systematic Review. JAMA 2015;314(14):1498–506.
- ↑ LeWinter MM, et al. Clinical practice. Acute pericarditis. N Engl J Med. 2014 Dec 18;371(25):2410-6. PMID: 25517707.
- ↑ LeWinter MM. Clinical practice. Acute pericarditis. N Engl J Med. 2014 Dec 18;371(25):2410-6. doi: 10.1056/NEJMcp1404070. Review.
- ↑ Wang K, Asinger RW, and Marriott HJL. ST-segment Elevation in Conditions Other than Acute Myocardial Infarction. N Engl J Med 2003;349:2128-35.
- ↑ Bischof JE, Worrall C, Thompson P, et al. ST depression in lead aVL differentiates inferior ST-elevation myocardial infarction from pericarditis. Am J Emerg Med. 2016; 34(2):149-154.
- ↑ Chaubey VK and Chhabra L. Spodick’s Sign: A Helpful Electrocardiographic Clue to the Diagnosis of Acute Pericarditis. Perm J. 2014 Winter; 18(1): e122.
- ↑ Imazio M. A randomized trial of colchicine for acute pericarditis.N Engl J Med. 2013 Oct 17;369(16):1522-8 PDF
- ↑ ImazioM, BobbioM, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis. Circulation. 2005;112(13):2012-2016.
- ↑ Imazio M, Brucato A, Cumetti D, et al. Corticosteroids for recurrent pericar- ditis: high versus low doses: a nonran- domized observation. Circulation 2008; 118:667-71.
- ↑ Imazio M.Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (Colchicine for REcurrent pericarditis) trial. Arch Intern Med. 2005 Sep 26;165(17):1987-91.
- ↑ Imazio M. Controversial issues in the management of pericardial diseases.Circulation. 2010 Feb 23;121(7):916-28.PDF
